The following table shows the list of Horizon 2020 projects developed by "LIPOTYPE". Projects are ordered by starting date.
Click on table headers to rearrange data.
# | acronym | programme | role | EC contrib. | start | views |
---|---|---|---|---|---|---|
1 | LysoMod | H2020-EU.1.3.3. | participant | 0.00 | 2017-03-01 | 840 |
2 | RHAPSODY | H2020-EU.3.1.7. | participant | 418˙968.00 | 2016-04-01 | 698 |
3 | BEAt-DKD | H2020-EU.3.1.7. | participant | 300˙000.00 | 2016-09-01 | 1466 |
4 | REMEDIA | H2020-EU.3.1.2. | participant | 731˙250.00 | 2020-01-01 | 374 |
5 | ISLET | H2020-EU.3.1.3. | participant | 700˙000.00 | 2020-03-01 | 283 |
totale | 2˙150˙218.00 |
This organization collaborated with partners in 20 countries.
Within the project LysoMod this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | RO | Chronos | CHRONOS BIOSYSTEMS SRL (PRC) |
participant | UK | IntraBio | INTRABIO LTD (PRC) |
participant | RO | IBAR | INSTITUTUL DE BIOCHIMIE (REC) |
participant | PT | GenoMed | GENOMED, DIAGNOSTICOS DE MEDICINA MOLECULAR SA (PRC) |
partner | CL | UDD | UNIVERSIDAD DEL DESARROLLO (HES) |
partner | US | CHOP | THE CHILDREN'S HOSPITAL OF PHILADELPHIA NON PROFIT ORG (OTH) |
participant | IT | FTELE.IGM | FONDAZIONE TELETHON (REC) |
partner | CL | PUC | PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE (HES) |
coordinator | PT | IMM | INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES (REC) |
participant | UK | UOS | THE UNIVERSITY OF SUSSEX (HES) |
partner | AR | UBA | UNIVERSIDAD DE BUENOS AIRES (HES) |
participant | IL | WEIZMANN | WEIZMANN INSTITUTE OF SCIENCE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
Within the project RHAPSODY this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | FR | UPD | UNIVERSITE DE PARIS (HES) |
participant | NL | VUmc | STICHTING VUMC (REC) |
participant | IT | AOU TO | AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO (PUB) |
participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
participant | UK | Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | Sanofi | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | BE | JP | JANSSEN PHARMACEUTICA NV (PRC) |
participant | FR | CHRU Lille | CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE (HES) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | CH | SCIPROM | SCIPROM SARL (PRC) |
coordinator | CH | UNIL | UNIVERSITE DE LAUSANNE (HES) |
participant | IT | UNIPI | UNIVERSITA DI PISA (HES) |
participant | FR | UPD | UNIVERSITE PARIS DIDEROT - PARIS 7 (HES) |
participant | DE | TUD | TECHNISCHE UNIVERSITAET DRESDEN (HES) |
participant | SE | ULUND | LUNDS UNIVERSITET (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | FR | Servier | INSTITUT DE RECHERCHES SERVIER (PRC) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | BE | ULB | UNIVERSITE LIBRE DE BRUXELLES (HES) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
participant | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
participant | DE | EKUT | EBERHARD KARLS UNIVERSITAET TUEBINGEN (HES) |
participant | UK | Imperial | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE (HES) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
participant | FR | CNRS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS (REC) |
Within the project BEAt-DKD this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | US | JDRF | JDRF INTERNATIONAL (REC) |
participant | US | AbbVie | ABBVIE INC (PRC) |
participant | FI | UEF | ITA-SUOMEN YLIOPISTO (HES) |
participant | NL | Astellas | ASTELLAS PHARMA EUROPE BV (PRC) |
participant | UK | Eli Lilly | Eli Lilly and Company Limited (PRC) |
participant | DE | SANOFI | SANOFI-AVENTIS DEUTSCHLAND GMBH (PRC) |
participant | DE | Bayer | Bayer Pharma AG (PRC) |
participant | DE | BI | BOEHRINGER INGELHEIM INTERNATIONALGMBH (PRC) |
participant | FR | CHUB | CHU HOPITAUX DE BORDEAUX (HES) |
participant | CH | SIB | SIB INSTITUT SUISSE DE BIOINFORMATIQUE (REC) |
participant | IT | IRFMN | ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI (REC) |
participant | IT | UBA | UNIVERSITA DEGLI STUDI DI BARI ALDO MORO (HES) |
participant | US | UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN | UNIVERSITY OF MICHIGAN THE REGENTS OF THE UNIVERSITY OF MICHIGAN (HES) |
participant | AT | MUI | MEDIZINISCHE UNIVERSITAT INNSBRUCK (HES) |
participant | DE | UKE | UNIVERSITAETSKLINIKUM HAMBURG-EPPENDORF (HES) |
participant | UK | UNEXE | THE UNIVERSITY OF EXETER (HES) |
participant | DE | UKER | UNIVERSITATSKLINIKUM ERLANGEN (HES) |
participant | DE | UKLFR | UNIVERSITAETSKLINIKUM FREIBURG (HES) |
participant | DE | RCI | KLINIKUM DER UNIVERSITAET REGENSBURG (HES) |
coordinator | SE | LU | LUNDS UNIVERSITET (HES) |
participant | FI | UTU | TURUN YLIOPISTO (HES) |
participant | UK | UHULL | UNIVERSITY OF HULL (HES) |
participant | NL | UMCG | ACADEMISCH ZIEKENHUIS GRONINGEN (HES) |
participant | DK | Novo Nordisk | NOVO NORDISK A/S (PRC) |
participant | UK | UoB | UNIVERSITY OF BRISTOL (HES) |
participant | UK | UNIVLEEDS | UNIVERSITY OF LEEDS (HES) |
participant | UK | UNIVDUN | UNIVERSITY OF DUNDEE (HES) |
participant | UK | UOXF | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (HES) |
participant | AT | MUW | MEDIZINISCHE UNIVERSITAET WIEN (HES) |
participant | FI | UH | HELSINGIN YLIOPISTO (HES) |
Within the project REMEDIA this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | UK | CEGX | CAMBRIDGE EPIGENETIX LIMITED (PRC) |
participant | FR | LISA | UNIVERSITE DE PARIS (HES) |
participant | FR | CHIC | CENTRE HOSPITALIER INTERCOMMUNAL DE CRETEIL (PUB) |
participant | HU | LNI | LAURENT NIDDAM EUROPAI KOZOSSEGI JOGASZ IRODA (PRC) |
participant | CH | DMI | DATA MINING INTERNATIONAL SA (PRC) |
participant | DK | DCS | KRAEFTENS BEKAEMPELSE (REC) |
participant | FR | LISA | UNIVERSITE PARIS DIDEROT - PARIS 7 (HES) |
participant | NO | UiT | UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET (HES) |
participant | FR | IT | INSERM TRANSFERT SA (PRC) |
participant | DE | Fraunhofer | FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (REC) |
participant | BE | KUL | KATHOLIEKE UNIVERSITEIT LEUVEN (HES) |
participant | EL | FORTH | IDRYMA TECHNOLOGIAS KAI EREVNAS (REC) |
coordinator | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |
Within the project ISLET this organization got in touch with:
role | cy | shortname | name |
---|---|---|---|
participant | DK | PANCRYOS IVS | PANCRYOS IVS (PRC) |
participant | DE | TUM-MED | KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN (HES) |
participant | BE | IDF EUROPE | FEDERATION INTERNATIONALE DU DIABETE REGION EUROPE AISBL (OTH) |
participant | NL | LUMC | ACADEMISCH ZIEKENHUIS LEIDEN (HES) |
coordinator | DK | UCPH | KOBENHAVNS UNIVERSITET (HES) |
participant | DE | HMGU | HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBH (REC) |
participant | FR | INSERM | INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (REC) |